Recruiting
Phase 1
Phase 2

Azeliragon

Sponsor:

Cantex Pharmaceuticals

Code:

NCT05766748

Conditions

Metastatic Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Azeliragon

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Cantex Pharmaceuticals on 2024-06-14.